iSpecimen (NASDAQ:ISPC – Get Free Report) and Nutex Health (NASDAQ:NUTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.
Profitability
This table compares iSpecimen and Nutex Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| iSpecimen | -172.48% | -395.15% | -121.72% |
| Nutex Health | 10.76% | 42.08% | 11.80% |
Analyst Recommendations
This is a breakdown of recent recommendations for iSpecimen and Nutex Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| iSpecimen | 0 | 0 | 0 | 0 | 0.00 |
| Nutex Health | 0 | 0 | 2 | 0 | 3.00 |
Institutional & Insider Ownership
13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Comparatively, 36.9% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares iSpecimen and Nutex Health”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| iSpecimen | $9.29 million | 0.79 | -$12.50 million | ($9.51) | -0.14 |
| Nutex Health | $479.95 million | 1.12 | $52.18 million | $11.89 | 8.16 |
Nutex Health has higher revenue and earnings than iSpecimen. iSpecimen is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
iSpecimen has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.17, suggesting that its stock price is 117% less volatile than the S&P 500.
Summary
Nutex Health beats iSpecimen on 12 of the 14 factors compared between the two stocks.
About iSpecimen
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
About Nutex Health
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
